mRNA Nanotherapy targeting Kv1.3 channels enables in vivo reprogramming of T cells for cancer therapy 2260072
Ameet Chimote(University of Cincinnati), Laura Conforti(University of Cincinnati), Abdulaziz Alshwimi(University of Cincinnati), Benjamin Hinrichs(University of Cincinnati), Marat Khodoun(University of Cincinnati), Anjali Iyer(University of Cincinnati)
Cited by 0
Related Papers
Wallerian degeneration: an emerging axon death pathway linking injury and disease
|Nature reviews. Neuroscience|2014|627
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene
|Nature Neuroscience|2001|616
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
|Cell Death and Differentiation|2014|263
A <i>Ufd2/D4Cole1e</i> chimeric protein and overexpression of <i>Rbp7</i> in the slow Wallerian degeneration ( <i>Wld</i> <sup>S</sup> ) mouse
|Proceedings of the National Academy of Sciences|2000|253